Techmer PM, a materials innovation company is proud to announce its collaboration with Premix Group in launching a next-generation, non-PFAS additive technology that enables high-performance fluid management in pipette tips, microplates, and diagnostic devices.
This proprietary solution from Techmer PM modifies surface energy at the molecular level, delivering clean fluid release, volumetric accuracy, and low extractables, without the need for fluorinated coatings or secondary treatments. The additive is embedded directly into the polymer matrix, ensuring permanent surface functionality and compatibility with sterilization and high-throughput molding environments.
“We are excited to work alongside Premix to bring this innovation to market,” said Daniel Raubenheimer, business unit director – engineered compounds of Techmer PM. “Their commitment to sustainability and technical excellence aligns perfectly with our mission to deliver safer, smarter materials for the life sciences industry.”
Also Read: GI Corporation Expands U.S. Manufacturing Facilities to Strengthen Wescon Product Lines
Key product advantages include:
- Built-in surface modification for consistent performance across molded parts
- High contact angles for optimal fluid release
- Customizable loadings (e.g., 4% and 8%) to balance hydrophobicity and clarity
This collaboration comes at a critical time as global regulations, including EPA and REACH, accelerate the phase-out of PFAS in medical and consumer products. Techmer PM’s solution offers a futureproof alternative that meets the performance demands of modern labware while supporting environmental and regulatory goals.
“At Premix, we are committed to advancing sustainable material solutions that meet the highest performance standards in healthcare and diagnostics. Partnering with Techmer PM enables us to combine our expertise in functional plastics with their innovation in additive technology, delivering PFAS-free alternatives that support both patient safety and environmental responsibility,” said Eira Kärjä, business director healthcare, Premix Group.
SOURCE: GlobeNeswire